Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

DSE:SQURPHARMA Revenue

Square Pharmaceuticals PLC. had revenue of 21.59B BDT in the quarter ending September 30, 2025, with 21.64% growth. This brings the company's revenue in the last twelve months to 80.13B, up 14.41% year-over-year. In the fiscal year ending June 30, 2025, Square Pharmaceuticals PLC. had annual revenue of 76.29B with 8.83% growth.

• Revenue (ttm): 80.13B
• Revenue Growth: +14.41%
• P/S Ratio: 2.23
• Revenue / Employee: 5.03M
• Employees: 15,937
• Market Cap: 178.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	76.29B	6.19B	8.83%
Jun 30, 2024	70.10B	9.39B	15.47%
Jun 30, 2023	60.71B	3.11B	5.40%
Jun 30, 2022	57.60B	6.89B	13.60%
Jun 30, 2021	50.70B	4.83B	10.52%